Determinants and Changes Associated With Aldosterone Breakthrough After Angiotensin II Receptor Blockade in Patients With Type 2 Diabetes With Overt Nephropathy

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.06960712